Fig. 7
From: Multifunctional nanoparticle-mediated combining therapy for human diseases
a The therapy strategies for AS include reducing lipid deposition, dissolving platelet thrombus and reducing inflammation. b The structure of rHDL. rHDL mainly comprises phospholipids and apoAI; the structure includes a hydrophobic core and a hydrophilic shell. c RCT process of HDL. Pre-HDL turns into HDL by combining cholesterol, promotes the transformation of foam cells into normal cells, and transports cholesterol to the liver for elimination. Parts of the figure were drawn using Servier Medical Art licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/)
